Tag: immune tolerance

Advancing Research

Research Resources

Join the iCureCeliac Patient Registry
Why Enroll in a Celiac Disease Trial
Qualify for a Celiac Disease Trial
Future Therapies for Celiac Disease
GlutenDetect Gluten Exposure Test Kit
Research News
Join the
iCureCeliac Registry
Qualify for a
Trial
Apply for a Research Award

For Researchers

Research Awards and Prizes
NASPGHAN Diagnosis Tool
Patient Recruitment Services
Access iCureCeliac Registry Data
NIH Funding for Celiac Disease Research
Department of Defense Funding for Celiac Disease Research
Join the CDF Research Working Group
Join the
iCureCeliac Registry
Qualify for a
Trial
Apply for a Research Award

Get Involved

Advocacy

Become a Policy Advocate
Public Policy Priorities
Contact Your Members of Congress
Federal Benefits
Celiac Disease Management in Schools Training Program
Advocacy News
Virtual
Celiac and Nutrition Education Classes
Become a Policy Advocate
Advocacy News

Join the Effort

Ways To Give
Join Team Gluten-Free
Social Media Toolkit
Events
Get Phone Advice
Sign Up For Email Updates
Virtual
Celiac and Nutrition Education Classes
Become a Policy Advocate
Advocacy News

5/22/2024

Anokion Announces New Clinical Data from ACeD-it Trial Supporting KAN-101 as a Potential Disease-Modifying Treatment for Celiac Disease

The Celiac Disease Foundation is pleased to share important research and clinical trial news from Anokion, a biotechnology company evaluating a treatment for celiac disease. Using our iQualifyCeliac screening platform,…

9/6/2019

ActoBio Announces Phase 1b/2a Trial for ActoBiotics® AG017

ActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.

Continue to link

About the Disease

Gluten-Free Resources

Research Resources

For Researchers

Advocacy

Join the Effort

About Us

Support the Foundation

About Celiac Disease

About the Disease

Gluten-Free Resources

Advancing Research

Research Resources

For Researchers

Get Involved

Advocacy

Join the Effort

About the Foundation

About Us

Support the Foundation

Featured News

Anokion Announces New Clinical Data from ACeD-it Trial Supporting KAN-101 as a Potential Disease-Modifying Treatment for Celiac Disease

ActoBio Announces Phase 1b/2a Trial for ActoBiotics® AG017

Recent Posts

Search the archive

Categories

Marilyn's Message

Celiac Disease Foundation

About Celiac Disease

About the Disease

Gluten-Free Resources

Advancing Research

Research Resources

For Researchers

Get Involved

Advocacy

Join the Effort

About the Foundation

About Us

Support the Foundation

Featured News

Tag: immune tolerance

Anokion Announces New Clinical Data from ACeD-it Trial Supporting KAN-101 as a Potential Disease-Modifying Treatment for Celiac Disease

ActoBio Announces Phase 1b/2a Trial for ActoBiotics® AG017

Search the blog

Recent Posts

Search the archive

Categories

Marilyn's Message